Overview

Clarithromycin in Active Crohn's Disease

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
Clarithromycin may be an effective therapy in Crohn's disease. It is a broad spectrum antibiotic. Crohn's disease, the investigators think, is in some way related to bacteria, which reside in the bowel. Previous studies of different types of antibiotic in Crohn's disease have shown encouraging results. Clarithromycin alters the bacteria in the bowel and gets into cells in the bowel which may contain bacteria. There is some evidence that clarithromycin can stimulate the immune system and improve the function of cells involved in killing bacteria in the bowel.
Phase:
Phase 3
Details
Lead Sponsor:
Royal Liverpool University Hospital
Collaborator:
Abbott
Treatments:
Clarithromycin